Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18408515 | MEDIAL STABILIZED ORTHOPAEDIC TIBIAL INSERT | January 2024 | December 2024 | Allow | 12 | 1 | 0 | No | No |
| 18507814 | INTRAOCULAR LENS HAVING HINGED HAPTIC STRUCTURES | November 2023 | October 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18369813 | PARTIAL GLENOID ARTHROPLASTY | September 2023 | December 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18465323 | SULCUS FIXATION FRAME | September 2023 | June 2024 | Allow | 9 | 2 | 0 | No | No |
| 18450667 | TIBIAL TRAY INSERTER | August 2023 | August 2024 | Allow | 12 | 1 | 0 | No | No |
| 17824061 | JOINT REPLACEMENT PROSTHESIS WITH TRANS-CORTICAL STEMS | May 2022 | November 2024 | Allow | 30 | 2 | 0 | Yes | No |
| 17735359 | SACROILIAC JOINT FUSION SYSTEM | May 2022 | November 2024 | Abandon | 31 | 2 | 1 | No | No |
| 17726168 | TIBIAL-TRAY SYSTEM | April 2022 | October 2024 | Allow | 30 | 2 | 0 | No | No |
| 17724925 | PROSTHETIC FEMORAL HEAD AND METHOD OF MAKING THE SAME | April 2022 | May 2024 | Allow | 25 | 1 | 0 | No | No |
| 17688346 | BONE IMPLANT DEVICE | March 2022 | May 2024 | Allow | 27 | 2 | 1 | Yes | No |
| 17653646 | REFRACTIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS, AND METHODS OF USE AND MANUFACTURE | March 2022 | October 2024 | Allow | 32 | 3 | 0 | No | No |
| 17653053 | LOW-PROFILE PROSTHESES, SYSTEMS, AND METHODS | March 2022 | July 2024 | Allow | 29 | 3 | 1 | No | No |
| 17652492 | TIBIAL TRAY INSERTER | February 2022 | October 2023 | Allow | 20 | 1 | 0 | No | No |
| 17561690 | FEMORAL PROSTHESIS AND KNEE PROSTHESIS WITH THEM | December 2021 | February 2024 | Allow | 25 | 2 | 0 | No | No |
| 17541683 | SURGICAL DEVICE AND METHOD FOR IMPLANTING AN ARTIFICIAL CORNEA | December 2021 | November 2023 | Allow | 23 | 1 | 0 | No | No |
| 17455893 | EXPANDABLE AUGMENT SYSTEM FOR ACETABULAR CUP | November 2021 | November 2023 | Allow | 24 | 2 | 1 | Yes | No |
| 17611941 | IMPLANTABLE NIPPLE | November 2021 | August 2024 | Allow | 33 | 0 | 0 | Yes | No |
| 17527830 | NEGATIVE POISSON`S RATIO MATERIALS FOR INTRAOCULAR LENSES | November 2021 | May 2024 | Allow | 30 | 2 | 1 | No | No |
| 17525402 | ACETABULAR IMPLANT AND METHOD FOR DEFORMING THIS IMPLANT | November 2021 | July 2024 | Allow | 32 | 2 | 1 | No | No |
| 17523047 | GLAUCOMA IMPLANT DEVICE | November 2021 | November 2023 | Allow | 24 | 2 | 0 | No | No |
| 17454089 | Self-accomodating lens and method for controlling a self-accomodating lens | November 2021 | September 2023 | Allow | 23 | 2 | 1 | Yes | No |
| 17604650 | MINIMALLY INVASIVE MAGNETIC VOCAL FOLD MANIPULATOR | October 2021 | October 2024 | Allow | 36 | 1 | 0 | No | No |
| 17501052 | Posterior Chamber Phakic Intraocular Lens | October 2021 | February 2024 | Allow | 28 | 2 | 0 | No | No |
| 17479947 | PARTIAL GLENOID ARTHROPLASTY | September 2021 | November 2023 | Abandon | 26 | 1 | 1 | No | No |
| 17381135 | DUAL MOBILITY ACETABULAR COMPONENT | July 2021 | July 2024 | Allow | 36 | 2 | 0 | No | No |
| 17372442 | MEDIAL STABILIZED ORTHOPAEDIC TIBIAL INSERT | July 2021 | May 2023 | Allow | 22 | 1 | 0 | No | No |
| 17413359 | FASTENING DEVICE FOR AN INTRAOCULAR LENS | June 2021 | July 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17312733 | SEPARATELY RELEASABLE AORTIC VALVE STENT | June 2021 | August 2023 | Allow | 26 | 2 | 0 | Yes | No |
| 17311057 | Animal Knee Joint Implant Reflecting Anatomical Structure of Animal | June 2021 | December 2024 | Allow | 43 | 2 | 0 | No | No |
| 17316420 | SYSTEM AND METHOD OF USE FOR CAROTID STENTING | May 2021 | February 2025 | Abandon | 46 | 4 | 0 | No | No |
| 17231374 | OPHTHALMIC LENSES HAVING AN EXTENDED DEPTH OF FOCUS FOR IMPROVING INTERMEDIATE VISION | April 2021 | October 2023 | Allow | 30 | 1 | 1 | Yes | No |
| 17282918 | CONSTRAINING MECHANISMS FOR SELECTIVE DEPLOYMENT AND ASSOCIATED METHODS | April 2021 | September 2024 | Allow | 42 | 1 | 0 | No | No |
| 17282403 | INTRODUCER DEVICES AND METHODS OF USE THEREOF | April 2021 | August 2024 | Allow | 40 | 1 | 1 | No | No |
| 17281889 | BIOSCAFFOLD FOR IN VIVO USE | March 2021 | September 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17273970 | ARTIFICIAL BLOOD VESSEL | March 2021 | January 2024 | Allow | 34 | 0 | 0 | Yes | No |
| 17150546 | Optical Material and Method for Modifying the Refractive Index | January 2021 | October 2024 | Allow | 45 | 3 | 0 | No | No |
| 17254573 | ACELLULAR DERMAL MATRIX, IN PARTICULAR FOR A MAMMARY PROSTHESIS | December 2020 | May 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17121502 | OPHTHALMIC IMPLANTS WITH EXTENDED DEPTH OF FIELD AND ENHANCED DISTANCE VISUAL ACUITY | December 2020 | December 2023 | Abandon | 36 | 1 | 0 | No | No |
| 16973816 | METHOD TO PRODUCE A PROSTHETIC COMPONENT, AND PROSTHETIC COMPONENT THUS PRODUCED | December 2020 | July 2024 | Abandon | 43 | 0 | 1 | No | No |
| 17054283 | CONTROLLING RATE OF BLOOD FLOW TO RIGHT ATRIUM | November 2020 | November 2024 | Allow | 48 | 1 | 1 | No | No |
| 17083054 | INTRAOCULAR LENS HAVING HINGED HAPTIC STRUCTURES | October 2020 | March 2024 | Abandon | 41 | 2 | 0 | Yes | No |
| 17080779 | RETINAL PROSTHESES | October 2020 | July 2024 | Allow | 44 | 1 | 0 | No | No |
| 17016628 | IMPERMEABLE INNER SHELL FOR A BREAST IMPLANT | September 2020 | August 2024 | Allow | 48 | 0 | 0 | No | No |
| 16920533 | ELECTROMYOGRAPHIC SENSING AND VISION MODIFICATION | July 2020 | March 2024 | Abandon | 44 | 1 | 1 | No | No |
| 16958306 | DIFFRACTIVE ARTIFICIAL OPHTHALMIC LENS WITH OPTIMISED APODIZATION AND METHOD FOR THE PRODUCTION OF SUCH ARTIFICIAL OPHTHALMIC LENS | June 2020 | November 2023 | Allow | 41 | 2 | 1 | No | No |
| 16910711 | ADJUSTABLE BREAST IMPLANT WITH INTEGRAL INJECTION PORT | June 2020 | May 2024 | Abandon | 47 | 1 | 0 | No | No |
| 16858299 | INCISED DESCEMET'S MEMBRANE AND METHODS OF MAKING AND USING | April 2020 | November 2024 | Allow | 55 | 3 | 1 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner MORALES, YASNIARY DE LA CARIDA works in Art Unit 3774 and has examined 34 patent applications in our dataset. With an allowance rate of 70.6%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.
Examiner MORALES, YASNIARY DE LA CARIDA's allowance rate of 70.6% places them in the 33% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by MORALES, YASNIARY DE LA CARIDA receive 1.44 office actions before reaching final disposition. This places the examiner in the 23% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by MORALES, YASNIARY DE LA CARIDA is 36 months. This places the examiner in the 37% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +19.0% benefit to allowance rate for applications examined by MORALES, YASNIARY DE LA CARIDA. This interview benefit is in the 62% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 45.5% of applications are subsequently allowed. This success rate is in the 96% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 40.0% of cases where such amendments are filed. This entry rate is in the 61% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 25.0% of allowed cases (in the 94% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.